COVID-19 vaccine strategies must focus on severe disease and global equity

COVID-19 vaccine strategies must focus on severe disease and global equity

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2022-01, Vol.399 (10322), p.406-410
Hauptverfasser: McIntyre, Peter B, Aggarwal, Rakesh, Jani, Ilesh, Jawad, Jaleela, Kochhar, Sonali, MacDonald, Noni, Madhi, Shabir A, Mohsni, Ezzeddine, Mulholland, Kim, Neuzil, Kathleen M, Nohynek, Hanna, Olayinka, Folake, Pitisuttithum, Punnee, Pollard, Andrew J, Cravioto, Alejandro
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19 - prevention & control
COVID-19 Vaccines - administration & dosage
Global Health
Health Priorities
Humans
SARS-CoV-2 - immunology
Vaccination Coverage
Vaccine Efficacy
Viewpoint
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 10322
container_start_page 406
container_title The Lancet (British edition)
container_volume 399
creator McIntyre, Peter B
Aggarwal, Rakesh
Jani, Ilesh
Jawad, Jaleela
Kochhar, Sonali
MacDonald, Noni
Madhi, Shabir A
Mohsni, Ezzeddine
Mulholland, Kim
Neuzil, Kathleen M
Nohynek, Hanna
Olayinka, Folake
Pitisuttithum, Punnee
Pollard, Andrew J
Cravioto, Alejandro
description
doi_str_mv 10.1016/S0140-6736(21)02835-X
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8676417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S014067362102835X</els_id><sourcerecordid>2612047738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c585t-2f4a091240236fb34e1820a0cc8677d1f5b734e5011e2503e028987bf3ac59883</originalsourceid><addsrcrecordid>eNqFUctO3EAQHEVBYSH5BNAcycHQ87YviaINrwiJQx7a22g8bi-DvB6YsVfi7-NlyYqcOLXUXV3VXUXIEYNTBkyf_QQmodBG6BPOPgMvhSoW78iMSSMLJc3iPZntIPvkIOd7AJAa1AeyL2TFuRbVjPyY3_65_l6wiq6d96FHmofkBlwGzHQ15oG20Y-Zxp5mXGNC2oSMLiN1fUOXXaxdR_FxDMPTR7LXui7jp5d6SH5fnP-aXxU3t5fX8283hVelGgreSgcV4xK40G0tJLKSgwPvS21Mw1pVm6mpgDHkCgROv1WlqVvhvKrKUhySL1veh7FeYeOxny7u7EMKK5eebHTB_j_pw51dxrWd-LVkZiI4eSFI8XHEPNhVyB67zvUYx2y5ZhykMWKjpbZQn2LOCdudDAO7ycE-52A3JlvO7HMOdjHtHb--cbf1z_gJ8HULwMmpdcBksw_Ye2xCQj_YJoY3JP4CLmeXTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612047738</pqid></control><display><type>article</type><title>COVID-19 vaccine strategies must focus on severe disease and global equity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McIntyre, Peter B ; Aggarwal, Rakesh ; Jani, Ilesh ; Jawad, Jaleela ; Kochhar, Sonali ; MacDonald, Noni ; Madhi, Shabir A ; Mohsni, Ezzeddine ; Mulholland, Kim ; Neuzil, Kathleen M ; Nohynek, Hanna ; Olayinka, Folake ; Pitisuttithum, Punnee ; Pollard, Andrew J ; Cravioto, Alejandro</creator><creatorcontrib>McIntyre, Peter B ; Aggarwal, Rakesh ; Jani, Ilesh ; Jawad, Jaleela ; Kochhar, Sonali ; MacDonald, Noni ; Madhi, Shabir A ; Mohsni, Ezzeddine ; Mulholland, Kim ; Neuzil, Kathleen M ; Nohynek, Hanna ; Olayinka, Folake ; Pitisuttithum, Punnee ; Pollard, Andrew J ; Cravioto, Alejandro</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>ISSN: 1474-547X</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(21)02835-X</identifier><identifier>PMID: 34922639</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>COVID-19 - prevention &amp; control ; COVID-19 Vaccines - administration &amp; dosage ; Global Health ; Health Priorities ; Humans ; SARS-CoV-2 - immunology ; Vaccination Coverage ; Vaccine Efficacy ; Viewpoint</subject><ispartof>The Lancet (British edition), 2022-01, Vol.399 (10322), p.406-410</ispartof><rights>2022 Elsevier Ltd</rights><rights>2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c585t-2f4a091240236fb34e1820a0cc8677d1f5b734e5011e2503e028987bf3ac59883</citedby><cites>FETCH-LOGICAL-c585t-2f4a091240236fb34e1820a0cc8677d1f5b734e5011e2503e028987bf3ac59883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S014067362102835X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34922639$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McIntyre, Peter B</creatorcontrib><creatorcontrib>Aggarwal, Rakesh</creatorcontrib><creatorcontrib>Jani, Ilesh</creatorcontrib><creatorcontrib>Jawad, Jaleela</creatorcontrib><creatorcontrib>Kochhar, Sonali</creatorcontrib><creatorcontrib>MacDonald, Noni</creatorcontrib><creatorcontrib>Madhi, Shabir A</creatorcontrib><creatorcontrib>Mohsni, Ezzeddine</creatorcontrib><creatorcontrib>Mulholland, Kim</creatorcontrib><creatorcontrib>Neuzil, Kathleen M</creatorcontrib><creatorcontrib>Nohynek, Hanna</creatorcontrib><creatorcontrib>Olayinka, Folake</creatorcontrib><creatorcontrib>Pitisuttithum, Punnee</creatorcontrib><creatorcontrib>Pollard, Andrew J</creatorcontrib><creatorcontrib>Cravioto, Alejandro</creatorcontrib><title>COVID-19 vaccine strategies must focus on severe disease and global equity</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 Vaccines - administration &amp; dosage</subject><subject>Global Health</subject><subject>Health Priorities</subject><subject>Humans</subject><subject>SARS-CoV-2 - immunology</subject><subject>Vaccination Coverage</subject><subject>Vaccine Efficacy</subject><subject>Viewpoint</subject><issn>0140-6736</issn><issn>1474-547X</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctO3EAQHEVBYSH5BNAcycHQ87YviaINrwiJQx7a22g8bi-DvB6YsVfi7-NlyYqcOLXUXV3VXUXIEYNTBkyf_QQmodBG6BPOPgMvhSoW78iMSSMLJc3iPZntIPvkIOd7AJAa1AeyL2TFuRbVjPyY3_65_l6wiq6d96FHmofkBlwGzHQ15oG20Y-Zxp5mXGNC2oSMLiN1fUOXXaxdR_FxDMPTR7LXui7jp5d6SH5fnP-aXxU3t5fX8283hVelGgreSgcV4xK40G0tJLKSgwPvS21Mw1pVm6mpgDHkCgROv1WlqVvhvKrKUhySL1veh7FeYeOxny7u7EMKK5eebHTB_j_pw51dxrWd-LVkZiI4eSFI8XHEPNhVyB67zvUYx2y5ZhykMWKjpbZQn2LOCdudDAO7ycE-52A3JlvO7HMOdjHtHb--cbf1z_gJ8HULwMmpdcBksw_Ye2xCQj_YJoY3JP4CLmeXTw</recordid><startdate>20220122</startdate><enddate>20220122</enddate><creator>McIntyre, Peter B</creator><creator>Aggarwal, Rakesh</creator><creator>Jani, Ilesh</creator><creator>Jawad, Jaleela</creator><creator>Kochhar, Sonali</creator><creator>MacDonald, Noni</creator><creator>Madhi, Shabir A</creator><creator>Mohsni, Ezzeddine</creator><creator>Mulholland, Kim</creator><creator>Neuzil, Kathleen M</creator><creator>Nohynek, Hanna</creator><creator>Olayinka, Folake</creator><creator>Pitisuttithum, Punnee</creator><creator>Pollard, Andrew J</creator><creator>Cravioto, Alejandro</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220122</creationdate><title>COVID-19 vaccine strategies must focus on severe disease and global equity</title><author>McIntyre, Peter B ; Aggarwal, Rakesh ; Jani, Ilesh ; Jawad, Jaleela ; Kochhar, Sonali ; MacDonald, Noni ; Madhi, Shabir A ; Mohsni, Ezzeddine ; Mulholland, Kim ; Neuzil, Kathleen M ; Nohynek, Hanna ; Olayinka, Folake ; Pitisuttithum, Punnee ; Pollard, Andrew J ; Cravioto, Alejandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c585t-2f4a091240236fb34e1820a0cc8677d1f5b734e5011e2503e028987bf3ac59883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 Vaccines - administration &amp; dosage</topic><topic>Global Health</topic><topic>Health Priorities</topic><topic>Humans</topic><topic>SARS-CoV-2 - immunology</topic><topic>Vaccination Coverage</topic><topic>Vaccine Efficacy</topic><topic>Viewpoint</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McIntyre, Peter B</creatorcontrib><creatorcontrib>Aggarwal, Rakesh</creatorcontrib><creatorcontrib>Jani, Ilesh</creatorcontrib><creatorcontrib>Jawad, Jaleela</creatorcontrib><creatorcontrib>Kochhar, Sonali</creatorcontrib><creatorcontrib>MacDonald, Noni</creatorcontrib><creatorcontrib>Madhi, Shabir A</creatorcontrib><creatorcontrib>Mohsni, Ezzeddine</creatorcontrib><creatorcontrib>Mulholland, Kim</creatorcontrib><creatorcontrib>Neuzil, Kathleen M</creatorcontrib><creatorcontrib>Nohynek, Hanna</creatorcontrib><creatorcontrib>Olayinka, Folake</creatorcontrib><creatorcontrib>Pitisuttithum, Punnee</creatorcontrib><creatorcontrib>Pollard, Andrew J</creatorcontrib><creatorcontrib>Cravioto, Alejandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McIntyre, Peter B</au><au>Aggarwal, Rakesh</au><au>Jani, Ilesh</au><au>Jawad, Jaleela</au><au>Kochhar, Sonali</au><au>MacDonald, Noni</au><au>Madhi, Shabir A</au><au>Mohsni, Ezzeddine</au><au>Mulholland, Kim</au><au>Neuzil, Kathleen M</au><au>Nohynek, Hanna</au><au>Olayinka, Folake</au><au>Pitisuttithum, Punnee</au><au>Pollard, Andrew J</au><au>Cravioto, Alejandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 vaccine strategies must focus on severe disease and global equity</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2022-01-22</date><risdate>2022</risdate><volume>399</volume><issue>10322</issue><spage>406</spage><epage>410</epage><pages>406-410</pages><issn>0140-6736</issn><issn>1474-547X</issn><eissn>1474-547X</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34922639</pmid><doi>10.1016/S0140-6736(21)02835-X</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2022-01, Vol.399 (10322), p.406-410
issn 0140-6736
1474-547X
1474-547X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8676417
source MEDLINE; Elsevier ScienceDirect Journals
subjects COVID-19 - prevention & control
COVID-19 Vaccines - administration & dosage
Global Health
Health Priorities
Humans
SARS-CoV-2 - immunology
Vaccination Coverage
Vaccine Efficacy
Viewpoint
title COVID-19 vaccine strategies must focus on severe disease and global equity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20vaccine%20strategies%20must%20focus%20on%20severe%20disease%20and%20global%20equity&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=McIntyre,%20Peter%20B&rft.date=2022-01-22&rft.volume=399&rft.issue=10322&rft.spage=406&rft.epage=410&rft.pages=406-410&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(21)02835-X&rft_dat=%3Cproquest_pubme%3E2612047738%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2612047738&rft_id=info:pmid/34922639&rft_els_id=S014067362102835X&rfr_iscdi=true